Newest A-Z
ADAPT-HEAT (Adaption of drug therapy during hot seasons)
>Federal Joint Committee | Innovation Fund
Planetary HealthData linkage
VAC-MAC: VACcination of patients with MS/Arthritis/Colitis
>Federal Joint Committee | Innovation Fund
Claims dataData preparation
OnCoPaTh – OncoCoaching and early palliative care in the therapy of incurable cancer
>Federal Joint Committee | Innovation Fund
Statistical AnalysesEvaluation
TOP – Transsectoral optimization of patient safety
>Federal Joint Committee | Innovation Fund
Supply curvesPharmacotherapy
CoRe-Web – Implementation and Evaluation of an Online Platform for Research Data
>Central Research Institute of Ambulatory Health Care in Germany (Zi)
EvaluationRegional Analyses
VersKiK – Care following childhood or adolescent cancer
>Federal Joint Committee | Innovation Fund
Data infrastructureData linkage
GestDiNa_basic – Aftercare for gestational diabetes
>Federal Joint Committee | Innovation Fund
Supply curvesDisease incidence
BARMER Pharmaceutical Report
>BARMER
PharmacotherapyClaims data
CoRe-Net – Cologne Research and Development Network
>Federal Ministry of Education and Research BMBF
Population healthData infrastructure
Risk evaluation and effectiveness of COVID19 vaccines RiCO
>Federal Ministry of Health
Data linkageClaims data
REVASK – Care analysis for myocardial revascularization therapy
>Federal Joint Committee | Innovation Fund
Supply curvesData linkage
EVITA – Evidence-based multi-medication program
>Federal Joint Committee | Innovation Fund
Development of GuidelinesSupply curves
Planetary Health in Health Services Research
>In development
Planetary HealthData linkage
DiViDe - Frequency of Diagnosis and Care of Hearing Impairment in Children and Adolescents in Germany
>KIND Hearing Foundation, International Hearing Foundation
Disease incidenceClaims data
Medication Catalogue
>National Association of Statutory Health Insurance Physicians
Literature ResearchDevelopment of Guidelines
isPO – integrated intersectoral psycho-oncology
>Federal Joint Committee | Innovation Fund
Data preparationClaims data
K-APAT – Outpatient parenteral antibiotic therapy in the Cologne metropolitan region
>Federal Joint Committee | Innovation Fund
Data preparationClaims data
SaarPHIR – Saarland nursing home care Integrated Regular
>Federal Joint Committee | Innovation Fund
PseudonymisationData linkage
Estimation of the prevalence and incidence of hyperkinetic disorder and its treatment
>Own resources
Disease incidenceClaims data
Supporting Integrated Care Service Provision in Estonia
>Ministry of Social Affairs Estonia | European Commission
Population healthData infrastructure
AdAM – Application of digitally supported pharmaceutical therapy
>Federal Joint Committee | Innovation Fund
Data infrastructureData preparation
Dent@Prevent – Implementation of claims data & PROMS into (dental) medical care
>Federal Joint Committee | Innovation Fund
Disease incidenceStatistical Analyses
Improvement of emergency care for heart attack patients in Berlin and Brandenburg
>Berlin-Brandenburg myocardial infarction registry
PseudonymisationRegister data
Evaluation of data from quality assurance stroke Baden-Württemberg
>University Hospital Heidelberg
Statistical AnalysesRegister data
Analysis of the prescription of Valproat and related substances over time
>Federal Institute for Drugs and Medical Devices BfArM
PharmacotherapyClaims data
ADVOCATE – Added Value for Oral Care
>Horizon 2020 | EU-Project
Data linkageRegional Analyses
INTEGRAL – 10-Year evaluation of the integrated care Gesundes Kinzigtal
>Federal Joint Committee | Innovation Fund
EvaluationCosts and Benefits
APVEL – Evaluation of specialised outpatient palliative care
>Federal Joint Committee | Innovation Fund
EvaluationSupply curves
Determination of the SHI target population for the indication diabetes mellitus type 2 using SHI routine data
>IQWiG
Claims dataDisease incidence
Chronic rheumatic diseases in women of childbearing age
>UCB Pharma GmbH
Statistical AnalysesClaims data
Operationalisation and frequency estimation of a statin intolerance
>Sanofi-Aventis Deutschland GmbH
Statistical AnalysesPharmacotherapy
Evaluation of the integrated care approache »Gesundes Kinzigtal«
>Gesundes Kinzigtal GmbH
EvaluationCosts and Benefits
CONTRIBUTE - Switch from OFF-Label & Best Supportive Care to approved therapies in various autoimmune diseases: Implementation, impact on disease progression and adverse events
>Federal Joint Committee | Innovation Fund
Statistical AnalysesSupply curves
METHODS
TOPICS
DATA
